Catherine Arsenault1, Mira Johri2, Arijit Nandi3, José M Mendoza Rodríguez4, Peter M Hansen5, Sam Harper3. 1. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. Electronic address: catherine.arsenault@mail.mcgill.ca. 2. Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada; Département de gestion, d'évaluation et de politique de santé, École de santé publique de l'Université de Montréal (ESPUM), Montreal, Canada. 3. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada; Institute for Health and Social Policy, McGill University, Montreal, Canada. 4. Statistics Canada, Ottawa, Canada. 5. Gavi, the Vaccine Alliance, Geneva, Switzerland.
Abstract
BACKGROUND: Important inequalities in childhood vaccination coverage persist between countries and population groups. Understanding why some countries achieve higher and more equitable levels of coverage is crucial to redress these inequalities. In this study, we explored the country-level determinants of (1) coverage of the third dose of diphtheria-tetanus-pertussis- (DTP3) containing vaccine and (2) within-country inequalities in DTP3 coverage in 45 countries supported by Gavi, the Vaccine Alliance. METHODS: We used data from the most recent Demographic and Health Surveys (DHS) conducted between 2005 and 2014. We measured national DTP3 coverage and the slope index of inequality in DTP3 coverage with respect to household wealth, maternal education, and multidimensional poverty. We collated data on country health systems, health financing, governance and geographic and sociocultural contexts from published sources. We used meta-regressions to assess the relationship between these country-level factors and variations in DTP3 coverage and inequalities. To validate our findings, we repeated these analyses for coverage with measles-containing vaccine (MCV). RESULTS: We found considerable heterogeneity in DTP3 coverage and in the magnitude of inequalities across countries. Results for MCV were consistent with those from DTP3. Political stability, gender equality and smaller land surface were important predictors of higher and more equitable levels of DTP3 coverage. Inequalities in DTP3 coverage were also lower in countries receiving more external resources for health, with lower rates of out-of-pocket spending and with higher national coverage. Greater government spending on heath and lower linguistic fractionalization were also consistent with better vaccination outcomes. CONCLUSION: Improving vaccination coverage and reducing inequalities requires that policies and programs address critical social determinants of health including geographic and social exclusion, gender inequality and the availability of financial protection for health. Further research should investigate the mechanisms contributing to these associations.
BACKGROUND: Important inequalities in childhood vaccination coverage persist between countries and population groups. Understanding why some countries achieve higher and more equitable levels of coverage is crucial to redress these inequalities. In this study, we explored the country-level determinants of (1) coverage of the third dose of diphtheria-tetanus-pertussis- (DTP3) containing vaccine and (2) within-country inequalities in DTP3 coverage in 45 countries supported by Gavi, the Vaccine Alliance. METHODS: We used data from the most recent Demographic and Health Surveys (DHS) conducted between 2005 and 2014. We measured national DTP3 coverage and the slope index of inequality in DTP3 coverage with respect to household wealth, maternal education, and multidimensional poverty. We collated data on country health systems, health financing, governance and geographic and sociocultural contexts from published sources. We used meta-regressions to assess the relationship between these country-level factors and variations in DTP3 coverage and inequalities. To validate our findings, we repeated these analyses for coverage with measles-containing vaccine (MCV). RESULTS: We found considerable heterogeneity in DTP3 coverage and in the magnitude of inequalities across countries. Results for MCV were consistent with those from DTP3. Political stability, gender equality and smaller land surface were important predictors of higher and more equitable levels of DTP3 coverage. Inequalities in DTP3 coverage were also lower in countries receiving more external resources for health, with lower rates of out-of-pocket spending and with higher national coverage. Greater government spending on heath and lower linguistic fractionalization were also consistent with better vaccination outcomes. CONCLUSION: Improving vaccination coverage and reducing inequalities requires that policies and programs address critical social determinants of health including geographic and social exclusion, gender inequality and the availability of financial protection for health. Further research should investigate the mechanisms contributing to these associations.
Authors: Anh Tuan Le Nguyen; Xuan Thanh Thi Le; Toan Thanh Thi Do; Cuong Tat Nguyen; Long Hoang Nguyen; Bach Xuan Tran; Huong Thi Le Journal: Biomed Res Int Date: 2019-02-21 Impact factor: 3.411
Authors: Lene Martinsen; Trygve Ottersen; Joseph L Dieleman; Philipp Hessel; Jonas Minet Kinge; Vegard Skirbekk Journal: BMJ Glob Health Date: 2018-01-03